About: Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review)
Creator	Carvalho, Félix Kostoff, Ronald Calina, Daniela Egorov, Alex Gabibov, Alexsandr Ishmukhametov, Aydar Oana Docea, Anca Petrakis, Shtilman, Michael Spandidos, A Tsatsakis, Aristidis Vinceti, Marco
source	Medline; PMC
abstract	In the current context of the pandemic triggered by SARS-COV-2, the immunization of the population through vaccination is recognized as a public health priority. In the case of SARS-COV-2, the genetic sequencing was done quickly, in one month. Since then, worldwide research has focused on obtaining a vaccine. This has a major economic impact because new technological platforms and advanced genetic engineering procedures are required to obtain a COVID-19 vaccine. The most difficult scientific challenge for this future vaccine obtained in the laboratory is the proof of clinical safety and efficacy. The biggest challenge of manufacturing is the construction and validation of production platforms capable of making the vaccine on a large scale.
has issue date	2020-05-06(xsd:dateTime)
bibo:doi	10.3892/ijmm.2020.4596
bibo:pmid	32377694
has license	cc-by-nc-nd
sha1sum (hex)	671d914b3e705e3e8bff9fe93a4d7b4bdd7a217a
schema:url	https://doi.org/10.3892/ijmm.2020.4596
resource representing a document's title	Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review)
has PubMed Central identifier	PMC7255458
has PubMed identifier	32377694
schema:publication	Int J Mol Med
resource representing a document's body	covid:671d914b3e705e3e8bff9fe93a4d7b4bdd7a217a#body_text
is schema:about of	named entity 'vaccine' named entity 'The' named entity 'This' named entity 'MANUFACTURING' named entity 'SEQUENCING' named entity 'SARS-cOV-2' named entity 'safety' named entity 'technological' named entity 'vaccine' named entity 'genetic engineering' named entity 'vaccination' named entity 'vaccine' named entity 'vaccine' named entity 'SARS-cOV-2' named entity 'production platforms' named entity 'immunization' named entity 'genetic engineering' named entity 'cOVId-19' named entity 'vaccine' named entity 'economic' named entity 'efficacy' named entity 'cOVId-19' named entity 'clinical development' named entity 'preclinical' named entity 'clinical trials' named entity 'vaccination' named entity 'RNA' named entity 'hygiene' named entity 'healthcare systems' named entity 'tocilizumab' named entity 'protein' named entity 'antigen' named entity 'Risk factors' named entity 'gastrointestinal' named entity 'vaccination' named entity 'Preclinical' named entity 'nucleocapsid' named entity 'controlled conditions' named entity 'virus' named entity 'cOVId-19' named entity 'immune dysfunction' named entity 'developed countries' named entity 'MERS' named entity 'vaccine' named entity 'inflammation' named entity 'SARS' named entity 'coronavirus' named entity 'signs of disease' named entity 'vaccine' named entity 'adverse reactions' named entity 'coronavirus' named entity 'protein' named entity 'vaccine' named entity 'gene' named entity 'epidemic' named entity 'SARS-cOV-2' named entity 'Adjuvant' named entity 'vaccine' named entity 'SV40' named entity 'vaccine' named entity 'SARS' named entity 'SARS-cOV-2' named entity 'SARS-cOV-2' named entity 'cell receptor' named entity 'SARS-CoV' named entity 'weakened immune systems' named entity 'vaccine' named entity 'recombinant proteins' named entity 'virus' named entity 'AcE2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software